Tarsus Pharmaceuticals Inc (TARS.O)

+ 收藏

现金流量表(Tarsus Pharmaceuticals Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年年报2025年三季报2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
起始日期 2025-01-012025-01-012025-01-012025-01-012024-01-012024-01-012024-01-012024-01-01
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表合并报表
报表年结日 12311231123112311231123112311231
原始币种 美元美元美元美元美元美元美元美元
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后上市后
经营活动产生的现金流量:
 净利润(元) 会员可见会员可见会员可见会员可见-115,554,000.00-92,441,000.00-69,021,000.00-35,731,000.00
 折旧及摊销(元) 会员可见会员可见会员可见会员可见-2,506,000.00-1,595,000.00-864,000.00-20,000.00
 基于股票的补偿费(元) 会员可见会员可见会员可见会员可见27,818,000.0020,415,000.0013,000,000.005,519,000.00
 投资损益(元) ----2,535,000.001,944,000.001,944,000.00-
 重估盈余(元) ----201,000.00201,000.00201,000.00201,000.00
 权益性投资损益(元) -----591,000.00591,000.00585,000.00
 汇兑损益(元) -会员可见会员可见--7,000.00-2,000.00-
 经营业务调整其他项目(元) 会员可见会员可见会员可见会员可见635,000.00462,000.00295,000.00246,000.00
 存货的减少(增加)(元) 会员可见会员可见会员可见会员可见-2,046,000.00-2,273,000.00-1,621,000.00-929,000.00
 预付款项及其他应收款减少(增加)(元) 会员可见会员可见会员可见会员可见-7,225,000.00631,000.001,614,000.00682,000.00
 应收账款及票据减少(增加)(元) 会员可见会员可见会员可见会员可见-30,139,000.00-12,538,000.00-12,908,000.00-13,264,000.00
 应付账款及票据增加(减少)(元) 会员可见会员可见会员可见会员可见40,337,000.0025,290,000.0019,422,000.0012,335,000.00
 应计费用及其他负债(元) 会员可见会员可见会员可见会员可见2,578,000.00-1,920,000.00-5,200,000.00-7,287,000.00
 经营业务其他项目(元) 会员可见会员可见会员可见会员可见339,000.00381,000.00356,000.00-126,000.00
 经营活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-83,027,000.00-60,845,000.00-52,193,000.00-37,789,000.00
投资活动产生的现金流量:
 购买固定资产支付的现金(元) 会员可见会员可见会员可见会员可见-1,567,000.00-1,495,000.00-1,213,000.00-174,000.00
 购买无形资产及其他资产支付的现金(元) -----5,000,000.00---
 投资支付现金(元) 会员可见会员可见会员可见会员可见-265,628,000.00-175,661,000.00-154,576,000.00-104,550,000.00
 投资业务其他项目(元) 会员可见会员可见会员可见会员可见73,000,000.0037,535,000.0013,040,000.002,500,000.00
 投资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见-199,195,000.00-139,621,000.00-142,749,000.00-102,224,000.00
融资活动产生的现金流量:
 新增借款(元) ------75,000,000.00-
 发行股份(元) 会员可见会员可见会员可见会员可见100,082,000.0099,423,000.0099,466,000.0098,604,000.00
 发行债券(元) ----75,000,000.0075,000,000.00--
 行使股票期权所得(元) 会员可见会员可见会员可见会员可见5,609,000.003,341,000.002,620,000.00802,000.00
 发行费用相关(元) -----3,523,000.00-3,523,000.00-3,484,000.00-
 筹资业务其他项目(元) -----22,512,000.00-22,512,000.00-22,512,000.009,365,000.00
 融资活动产生的现金流量净额(元) 会员可见会员可见会员可见会员可见154,656,000.00151,729,000.00151,090,000.00108,771,000.00
现金及现金等价物期初余额(元) 会员可见会员可见会员可见会员可见224,947,000.00224,947,000.00224,947,000.00224,947,000.00
现金及现金等价物增加(减少)额(元) 会员可见会员可见会员可见会员可见-127,566,000.00-48,737,000.00-43,852,000.00-31,242,000.00
现金及现金等价物期末余额(元) 会员可见会员可见会员可见会员可见97,381,000.00176,210,000.00181,095,000.00193,705,000.00
利息支付(元) 会员可见会员可见会员可见会员可见7,662,000.005,488,000.001,336,000.00868,000.00
补充资料其他项目(元) 会员可见会员可见会员可见会员可见1,582,000.005,460,000.00526,000.00659,000.00
公告日期 2026-02-232025-11-042025-08-062025-05-012025-02-252024-11-132024-08-082024-05-08
会计准则 美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则美国会计准则
审计意见
核数师

前瞻产业研究院